Therapeutic monitoring of antidepressants;Therapeutisches monitoring von trizyklischen antidepressiva

Psychopharmakotherapie

Volumn 10, Issue 1, 2003, Pages 11-14

  Hiemke, Christoph ^a   Dragicevic, A ^b   Fric, M ^b   Gaertner, I ^b   Grasmader K ^b   Hartter S ^b   Hermann, E ^b   Kuss, H J ^b   Laux, G ^b   Oehl, W ^b   Rao, M L ^b   Rollmann, N ^b   Weigmann, H ^b   Weber Labonte, M ^b   Muller M J ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b NONE

Author keywords

Therapeutic drug monitoring; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DOXEPIN; IMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SAFETY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0037324762     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Burke MJ, Preskorn SH. Therapeutic drug monitoring of antidepressants. Clin Pharmacokinetics 1999;37:147-65.
2. Fraser AD. Experience with a specific request form for antidepressant drug monitoring. Ther Drug Monit 1985;7:299-302.
3. Glassman A and the task force on the use of laboratory tests in psychiatry. Tricyclic antidepressants - blood level measurements and clinical outcome: an APA task force report. Am J Psychiatry 1985;142:155-62.
4. Hiemke C, Weigmann H, Härtter S, Mann K. Evidence Based Medicine. Therapeutisches Drug Monitoring von Psychopharmaka. Neurotransmitter 2000:11:52-5.
5. Hodgkiss AD, McCarthy PT, Sulke AN, Bridges PK. High dose tertiary amine tricyclic antidepressants in the treatment of severe refractory depression: the central role of serum concentration estimations. Human Psychopharmacology 1995;10:407-15.
6. Isacsson G, Bergman U, Wasserman D, Redfors I, et al. The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiatry 1996;8:153-60.
7. Lingjærde O, Ahlfors UG, Bech P, Dencker SJ, et al. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987;(Suppl 334):1-100.
8. Mitchell PB. Therapeutic drug monitoring of psychotropic medication. Br J Clin Pharmacol 2000;49:303-12.
9. Perry PJ, Pfohl BM, Holstad SG. The relationship between antidepressant response and tricyclic antidepressant serum concentrations. A retrospective analysis of the literature using logistic regression analysis. Clin Pharmacokinet 1987;13:381-92.
10. Preskorn SH, Fast GA. Therapeutic drug monitoring for tricyclic antidepressant: efficacy, safety, and cost effectiveness. J Clin Psychiatry 1992;52(Suppl):23-33.
11. Preskorn SH, Jerkovich GS. Central nervous system toxicity of tricyclic antidepressants. phenomenology, course, risk factors, and role of therapeutic drug monitoring. J Clin Psychopharmacology 1990;10:88-95.
12. Preskorn SH. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry 1989;50(Suppl):34-42.
13. Rao ML, Deister A, Laux G, Staberock U, et al. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse. Pharmacopsychiatry 1996;29:97-102.
14. Risch SC, Kalin NH, Janowsky DS, Huey LY. Indications and guidelines for serum tricyclic antidepressant concentration monitoring. J Clin Psychopharmacol 1981;1:59-63.
15. Simmons SA, Perry PJ, Rickert ED, Browne JL. Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients. J Affect Disord 1985;8:47-53.
16. Tonkin AL, Bochner, F. Therapeutic drug monitoring and patient outcome. Clin Pharmacokinetics 1994;27:169-74.
17. Ulrich S, Northoff G, Wurthmann C, Partscht G, et al. Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients: a therapeutic window relationship. Pharmacopsychiatry 2001;34:33-40.
18. Vuille F, Amey M, Baumann P. Use of serum level monitoring of antidepressants in clinical practice. Pharmacopsychiatry 1991;24:190-5.